Caveolae are plasma membrane invaginations, which have been implicated in endothelial transcytosis, endocytosis, potocytosis, and signal transduction. In addition to their well-defined morphology, caveolae are characterized by the presence of an integral membrane protein termed VIP21-caveolin. We have recently observed that lymphocytes have no detectable VIP21-caveolin and lack plasma membrane invaginations resembling caveolae.
line using the Semliki Forest virus expression system and show de novo formation of plasma membrane invaginations containing VIP21-caveolin. These invaginations appear homogeneous in size and morphologically indistinguishable from caveolae of nonlymphoid cells. Moreover, the glycosylphosphatidylinositol-anchored protein Thyl, patched by antibodies, redistributes to the newly formed caveolae. Our results show that VIP21-caveolin is a key structural component required for caveolar biogenesis.
Caveolae are specialized domains of the plasma membrane present in most mammalian cell types. While the function of these structures remains controversial, their morphology has been studied in great detail (1) . Caveolae generally appear as 50-to 90-nm vesicular invaginations of the plasma membrane with a characteristic bulb shape. Clusters of connected caveolae resembling bunches of grapes are often seen in adipocytes, endothelial cells, and fibroblasts. In contrast to clathrin-coated pits, caveolae do not show a well-defined coat by conventional transmission electron microscopy. However, filamentous material arranged in spiral or striated arrays on the cytoplasmic side of caveolae has been revealed by other electron microscopy techniques (2, 3) and is generally referred to as the caveolar coat. VIP21-caveolin, an integral membrane protein originally identified as a substrate for v-src (4) and a component of Golgi-derived transport vesicles (5) , was localized in caveolae by immunogold staining and proposed to play a structural role (6, 7) . We have previously reported that the absence of detectable VIP21-caveolin correlates with the lack of caveolae in a lymphocyte cell line (8) . Similar results were obtained in N2a neuroblastoma cells (9) . Here we express VIP21-caveolin in our model lymphocyte cell line and analyze the plasma membrane morphology by electron microscopy. Consistent with its proposed structural role, expression of VIP21-caveolin induces formation of caveolae.
METHODS
Preparation of Recombinant Semliki Forest Virus (SFV). The recombinant SFV-VIP21 virus was prepared in baby hamster kidney (BHK) cells according to an established procedure (10, 11) . A suitable vector (pSFV-VIP21) had been previously constructed by cloning the dog VIP21-caveolin cDNA (5) in the Sma I restriction site of pSFV1 (Life Technologies, Grand Island, NY). BHK cells were electroporated with RNA obtained by in vitro transcription of pSFV-VIP21 and pSFV-Helperl. Twenty-four hours after electroporation, the culture supernatant of BHK cells was collected, layered on top of a 50% (vol/vol) glycerol cushion in SW40 tubes, and centrifuged for 2 h at 30,000 rpm (4°C). The viral pellet was then resuspended overnight in 1/50th of the original volume of TNE buffer (50 mM Tris HCl, pH 7.4/100 mM NaCl/0.5 mM EDTA). The control recombinant viruses SFV-rab8 and SFV-APP, encoding, respectively, the small GTPase rab8 and the f3-amyloid precursor protein (APP), were kindly provided by Vesa Olkkonen (European Molecular Biology Laboratory) and Mikael Simons (European Molecular Biology Laboratory), respectively.
Infection of2B2318 Lymphocytes. 2B2318 T hybridoma cells (12) were infected for 90 min at 37°C with 1:10 dilutions of the viral stocks in RPMI 1640 medium containing 0.2% bovine serum albumin and 20 mM Hepes, after which the infection medium was diluted 10-fold with normal culture medium, and the incubation was prolonged for 5 h.
Western Blot. For Western blot analysis, cells were washed with phosphate-buffered saline and lysed in reducing Laemmli buffer (50 mM Tris HCl, pH 6.8/2% SDS/10% glycerol/2% 2-mercaptoethanol). Cell lysates were then separated on either 15% (VIP21-caveolin and rab8) or 6% (APP) SDS/PAGE gels and blotted to nitrocellulose membranes as described (6) . The proteins were detected using an anticaveolin monoclonal antibody (Transduction Laboratories, Lexington, KY), a rabbit anti-rab8 antiserum, or the 22C11 anti-APP monoclonal antibody (Boehringer Mannheim), followed by the appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies and ECL (Amersham).
Electron Microscopy. The electron microscopic analysis of VIP21-caveolin distribution was performed as described (6) . Briefly, 2B2318 lymphocytes infected with SFV-VIP21 were fixed, and ultrathin frozen sections were labeled with a rabbit antiserum to the N terminus of VIP21-caveolin (6) and protein A-gold. To determine the number of caveolae-like profiles in cells expressing different levels of VIP21-caveolin, cells were photographed at random at a primary magnification of x 12,500. For each cell, two fields were photographed, and the results were pooled to minimize variation in labeling within different regions of the same cell. The number of caveolar profiles (arbitrarily defined as 50-70 nm clearly delineated uncoated circular profiles) and the number of gold particles in the field were then determined after projecting the images using a photographic enlarger. Labeled or unlabeled membrane profiles fitting the above criteria were included in the analysis irrespective of a visible continuity with the plasma membrane. The number of gold particles per caveolar profile was determined on the same negatives. In this case, the values from a number of cells were pooled to 
RESULTS
Expression of VIP21-Caveolin in Lymphocytes. To investigate whether the lack of caveolae in lymphocytes was due to the absence of VIP21-caveolin, the protein was expressed in our model lymphocyte cell line, the T-cell hybridoma 2B2318, by using the SFV expression system (10) . This system, which allows high levels of transient expression with minor cytopathic effects, has been previously used to express a myc-tagged derivative of VIP21-caveolin in rat hippocampal neurons (11) . Like its parental cell line BW5147 (13) , 2B2318 lymphocytes were efficiently infected by wild-type SFV. Similarly, over 30% of 2B2318 cells could be infected by the recombinant virus encoding dog VIP21-caveolin (SFV-VIP21) or by the control recombinant viruses encoding the small GTPase rab8 (SFVrab8) and the APP (SFV-APP), as determined by immunofluorescence (data not shown). Expression of the proteins was checked by Western blotting (Fig. 1) . Taking into account that only about one-third of the lymphocytes were infected, the level of VIP21-caveolin expression obtained in infected 2B2318 was comparable to the endogenous expression in MDCKII cells. The two isoforms of VIP21-caveolin expressed by MDCKII cells (6) probably reflect a different translational initiation codon (P. Dupree, R. Kellner, K.S., and T. Kurzchalia, unpublished data) and are present in different relative amounts depending on the cell line studied (results not shown). Lymphocytes infected with SFV-VIP21 preferentially express the larger form of VIP21-caveolin.
Distribution of VIP21-Caveolin. Localization of VIP21-caveolin was analyzed by immunoelectron microscopy using antibodies to the N terminus of the protein. These antibodies were previously shown to preferentially recognize the protein present on the plasma membrane in Madin-Darby canine kidney, A431, and BHK cells, in contrast to antibodies to the C terminus, which also detect the protein located in the Golgi apparatus (6) . Lymphocytes expressing low levels of VIP21-caveolin showed only a dispersed labeling over the plasma membrane ( Fig. 2A Inset) . However, in highly expressing cells, most of the staining appeared in uniformly sized vesicular profiles on the plasma membrane or in close proximity to it (Fig. 2) . Noninfected cells or cells infected with SFV-APP did not show any significant labeling for VIP21-caveolin. Cells infected with SFV-APP showed a uniform distribution of APP on their surface (results not shown).
To examine the possible relationship between the expression of VIP21-caveolin and the formation of the putative caveolae, we quantitated the number of caveolar profiles in cells expressing different levels of VIP21-caveolin (Fig. 3A) . A clear correlation between the cellular expression of VIP21-caveolin and the number of caveolar profiles was apparent. However, the number of gold particles per caveolar profile was similar in cells expressing high or low levels of VIP21-caveolin (Fig. 3B ).
Surface Labeling of Newly Formed Caveolae. To study the plasma membrane morphology in more detail, we labeled the cells with CT-HRP (8, 14) . CT-HRP binds specifically to the ganglioside GM1, which was shown to be concentrated in caveolae of A431 cells by CT-gold labeling (15) . In contrast to noninfected cells (8) , 2B2318 cells expressing VIP21-caveolin show surface invaginations with the morphology of caveolae heavily labeled by the HRP reaction product (Fig. 4 A and B) . The 60-nm uncoated profiles are seen as single pits, vesicular profiles (Fig. 4C) , or in highly characteristic clusters (Fig. 4B) . Identical caveolar structures are commonly seen in A431 cells (Fig. 4D ) but never in untransfected lymphocytes (8) induced upon VIP21-caveolin expression have a remarkably constant diameter of between 50 and 60 nm (Fig. 5) .
Next, we investigated whether the GPI-anchored protein Thyl, after clustering on the cell surface with antibodies, was concentrated in the newly formed caveolae. In contrast to the random distribution observed in wild-type lymphocytes (8), Thyl appeared enriched in structures of caveolar morphology in lymphocytes expressing VIP21-caveolin (Fig. 6) . By quantitation, 9% of the Thyl-gold particles were found in caveolaelike invaginations, which occupied only 0.5% of the plasma membrane. Therefore, as in other cells, clustered GPIanchored proteins are enriched in caveolar invaginations.
DISCUSSION
The present study shows that caveolae are induced on the surface of 2B2318 cells upon expression of VIP21-caveolin. We base this conclusion on the well-established morphological criteria, which have been used to define the plasmalemmal invaginations called caveolae since their discovery (16, 17) . Based on these criteria, as well as the labeling for VIP21-caveolin and the presence of an antibody-clustered GPIanchored protein, the de novo-produced caveolae are indistinguishable from those in fibroblasts.
How does the expression of VIP21-caveolin lead to the formation of caveolae? One possibility is that VIP21-caveolin Cell Biology: Fra et al.
Proc. Natl. Acad. Sci. USA 92 (1995) k~~~~~~~~~~~~k *Ar jt;,~~~~~~~~*~45 */ expression is required as an essential but minor factor to bring endogenous structural components together to form caveolae. Alternatively VIP21-caveolin itself may be the required structural element that modifies the plasma membrane morphology and composition. While we cannot rule out either possibility, the latter is more consistent with the available evidence. First, a threshold level of cellular VIP21-caveolin was apparently required for caveolar formation, but above this threshold the density of VIP21-caveolin within individual caveolae appeared to be fairly constant. Second, the level of VIP21-caveolin in caveolae, estimated by immunogold labeling, was remarkably high [assuming a labeling efficiency of 5% (6), up to 10,000 VIP21-caveolin molecules per ALm2]. The molecular events leading to caveolar formation remain to be unraveled. Recently it was shown that VIP21-caveolin rapidly forms oligomers after synthesis in the endoplasmic reticulum, but only later in the exocytic pathway do the oligomers become insoluble in nonionic detergents (18) . This insolubility may reflect interactions with lipid components and may be essential for the generation of the caveolar membrane domain.
Expression of VIP21-caveolin to form caveolae may also have a physiological role. Induction of VIP21-caveolin has been observed during adipogenesis and correlates with an increased number of caveolae (19) . Taken together, these data are consistent with the previous conclusion that VIP21-caveolin is a component of the caveolar coat (7) redistribution of surface VIP21-caveolin to the Golgi apparatus without affecting the number and structure of caveolae in human fibroblasts (20) . Further experiments will be required to address this apparent discrepancy and determine the exact role of VIP21- caveolin in the biogenesis and function of caveolae. Nevertheless, the ability to generate caveolae through expression of a single protein provides an experimental system in which the structure, function, and biogenesis of caveolae can be studied.
